NO781066L - Fremgangsmaate til fremstilling av nye steroider av androstanserien - Google Patents
Fremgangsmaate til fremstilling av nye steroider av androstanserienInfo
- Publication number
- NO781066L NO781066L NO781066A NO781066A NO781066L NO 781066 L NO781066 L NO 781066L NO 781066 A NO781066 A NO 781066A NO 781066 A NO781066 A NO 781066A NO 781066 L NO781066 L NO 781066L
- Authority
- NO
- Norway
- Prior art keywords
- androsta
- dien
- derivative
- general formula
- derivatives
- Prior art date
Links
- 238000000034 method Methods 0.000 title claims description 12
- 150000003431 steroids Chemical class 0.000 title description 8
- QZLYKIGBANMMBK-UGCZWRCOSA-N 5α-Androstane Chemical class C([C@@H]1CC2)CCC[C@]1(C)[C@@H]1[C@@H]2[C@@H]2CCC[C@@]2(C)CC1 QZLYKIGBANMMBK-UGCZWRCOSA-N 0.000 title 1
- 150000001875 compounds Chemical class 0.000 claims description 11
- 239000004480 active ingredient Substances 0.000 claims description 6
- KWGKDLIKAYFUFQ-UHFFFAOYSA-M lithium chloride Chemical compound [Li+].[Cl-] KWGKDLIKAYFUFQ-UHFFFAOYSA-M 0.000 claims description 6
- 239000012359 Methanesulfonyl chloride Substances 0.000 claims description 4
- 230000018044 dehydration Effects 0.000 claims description 4
- 238000006297 dehydration reaction Methods 0.000 claims description 4
- QARBMVPHQWIHKH-UHFFFAOYSA-N methanesulfonyl chloride Chemical group CS(Cl)(=O)=O QARBMVPHQWIHKH-UHFFFAOYSA-N 0.000 claims description 4
- 239000000825 pharmaceutical preparation Substances 0.000 claims description 4
- 238000006243 chemical reaction Methods 0.000 claims description 3
- -1 alkanesulfonyl halide Chemical class 0.000 claims description 2
- 239000003937 drug carrier Substances 0.000 claims description 2
- 238000010438 heat treatment Methods 0.000 claims description 2
- 125000004435 hydrogen atom Chemical group [H]* 0.000 claims description 2
- 238000004519 manufacturing process Methods 0.000 claims description 2
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 claims description 2
- 125000001424 substituent group Chemical group 0.000 claims description 2
- 125000004390 alkyl sulfonyl group Chemical group 0.000 claims 1
- ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-Dimethylformamide Chemical compound CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 description 6
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 description 6
- 238000002360 preparation method Methods 0.000 description 5
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 5
- JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical compound C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 description 4
- 239000004615 ingredient Substances 0.000 description 4
- 238000001819 mass spectrum Methods 0.000 description 4
- 238000002844 melting Methods 0.000 description 4
- 230000008018 melting Effects 0.000 description 4
- 239000000203 mixture Substances 0.000 description 4
- 239000008194 pharmaceutical composition Substances 0.000 description 4
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 3
- 239000000051 antiandrogen Substances 0.000 description 3
- 238000007920 subcutaneous administration Methods 0.000 description 3
- 230000000699 topical effect Effects 0.000 description 3
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 2
- 201000004384 Alopecia Diseases 0.000 description 2
- QGZKDVFQNNGYKY-UHFFFAOYSA-N Ammonia Chemical compound N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 description 2
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 2
- 241001465754 Metazoa Species 0.000 description 2
- 239000013543 active substance Substances 0.000 description 2
- 230000002280 anti-androgenic effect Effects 0.000 description 2
- 239000006071 cream Substances 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- 239000000839 emulsion Substances 0.000 description 2
- 239000000499 gel Substances 0.000 description 2
- 239000006210 lotion Substances 0.000 description 2
- 229960004719 nandrolone Drugs 0.000 description 2
- 239000002244 precipitate Substances 0.000 description 2
- UMJSCPRVCHMLSP-UHFFFAOYSA-N pyridine Natural products COC1=CC=CN=C1 UMJSCPRVCHMLSP-UHFFFAOYSA-N 0.000 description 2
- 239000011541 reaction mixture Substances 0.000 description 2
- SQGYOTSLMSWVJD-UHFFFAOYSA-N silver(1+) nitrate Chemical compound [Ag+].[O-]N(=O)=O SQGYOTSLMSWVJD-UHFFFAOYSA-N 0.000 description 2
- 239000000725 suspension Substances 0.000 description 2
- 208000002874 Acne Vulgaris Diseases 0.000 description 1
- 101710134784 Agnoprotein Proteins 0.000 description 1
- 206010020112 Hirsutism Diseases 0.000 description 1
- NTIZESTWPVYFNL-UHFFFAOYSA-N Methyl isobutyl ketone Chemical compound CC(C)CC(C)=O NTIZESTWPVYFNL-UHFFFAOYSA-N 0.000 description 1
- UIHCLUNTQKBZGK-UHFFFAOYSA-N Methyl isobutyl ketone Natural products CCC(C)C(C)=O UIHCLUNTQKBZGK-UHFFFAOYSA-N 0.000 description 1
- 241000699670 Mus sp. Species 0.000 description 1
- 206010039792 Seborrhoea Diseases 0.000 description 1
- 229910004298 SiO 2 Inorganic materials 0.000 description 1
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 1
- 206010000496 acne Diseases 0.000 description 1
- 230000001154 acute effect Effects 0.000 description 1
- 231100000360 alopecia Toxicity 0.000 description 1
- 229910021529 ammonia Inorganic materials 0.000 description 1
- 150000001440 androstane derivatives Chemical class 0.000 description 1
- 150000001441 androstanes Chemical class 0.000 description 1
- 230000037396 body weight Effects 0.000 description 1
- 238000010828 elution Methods 0.000 description 1
- 230000003676 hair loss Effects 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 231100000053 low toxicity Toxicity 0.000 description 1
- 229910052757 nitrogen Inorganic materials 0.000 description 1
- 239000002674 ointment Substances 0.000 description 1
- 235000008390 olive oil Nutrition 0.000 description 1
- 239000004006 olive oil Substances 0.000 description 1
- 239000003960 organic solvent Substances 0.000 description 1
- 239000000047 product Substances 0.000 description 1
- 208000008742 seborrheic dermatitis Diseases 0.000 description 1
- 239000000741 silica gel Substances 0.000 description 1
- 229910002027 silica gel Inorganic materials 0.000 description 1
- 229910001961 silver nitrate Inorganic materials 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- 230000009885 systemic effect Effects 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 235000015112 vegetable and seed oil Nutrition 0.000 description 1
- 239000008158 vegetable oil Substances 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J61/00—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton has been modified by contraction of only one ring by one or two atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Dermatology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Animal Behavior & Ethology (AREA)
- Engineering & Computer Science (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Steroid Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Cosmetics (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB13003/77A GB1566905A (en) | 1977-03-28 | 1977-03-28 | Steroids of the a-nor-androstane and a-nor-estrane series |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| NO781066L true NO781066L (no) | 1978-09-29 |
Family
ID=10015057
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO781066A NO781066L (no) | 1977-03-28 | 1978-03-28 | Fremgangsmaate til fremstilling av nye steroider av androstanserien |
Country Status (21)
| Country | Link |
|---|---|
| US (1) | US4130665A (fr) |
| JP (1) | JPS53119862A (fr) |
| AT (1) | AT361641B (fr) |
| AU (1) | AU515232B2 (fr) |
| BE (1) | BE865391A (fr) |
| CA (1) | CA1101409A (fr) |
| CH (1) | CH639109A5 (fr) |
| DE (1) | DE2813384A1 (fr) |
| DK (1) | DK145913C (fr) |
| ES (1) | ES468293A1 (fr) |
| FI (1) | FI64378C (fr) |
| FR (1) | FR2385738A1 (fr) |
| GB (1) | GB1566905A (fr) |
| HU (1) | HU174575B (fr) |
| IE (1) | IE46592B1 (fr) |
| IT (1) | IT7867630A0 (fr) |
| LU (1) | LU79318A1 (fr) |
| NL (1) | NL7803227A (fr) |
| NO (1) | NO781066L (fr) |
| NZ (1) | NZ186788A (fr) |
| ZA (1) | ZA781752B (fr) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS58162512A (ja) * | 1982-03-20 | 1983-09-27 | Kazuoki Tsuchiya | 若禿及び円型脱毛の発毛剤 |
| JPS60142908A (ja) * | 1983-12-29 | 1985-07-29 | Kanebo Ltd | 養毛化粧料 |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR1532508A (fr) * | 1967-05-29 | 1968-07-12 | Roussel Uclaf | Nouveau procédé de préparation de dérivés stéroïdes insaturés à cycle a modifié |
| GB1550343A (en) * | 1975-07-16 | 1979-08-15 | Gist Brocades Nv | Androstane derivatives |
-
1977
- 1977-03-28 GB GB13003/77A patent/GB1566905A/en not_active Expired
-
1978
- 1978-03-22 IT IT7867630A patent/IT7867630A0/it unknown
- 1978-03-23 AT AT207778A patent/AT361641B/de not_active IP Right Cessation
- 1978-03-23 NZ NZ186788A patent/NZ186788A/xx unknown
- 1978-03-28 FI FI780938A patent/FI64378C/fi not_active IP Right Cessation
- 1978-03-28 AU AU34517/78A patent/AU515232B2/en not_active Expired
- 1978-03-28 NO NO781066A patent/NO781066L/no unknown
- 1978-03-28 FR FR7808961A patent/FR2385738A1/fr active Granted
- 1978-03-28 US US05/891,288 patent/US4130665A/en not_active Expired - Lifetime
- 1978-03-28 HU HU78GI271A patent/HU174575B/hu unknown
- 1978-03-28 CH CH331278A patent/CH639109A5/de not_active IP Right Cessation
- 1978-03-28 NL NL7803227A patent/NL7803227A/xx not_active Application Discontinuation
- 1978-03-28 DK DK135678A patent/DK145913C/da not_active IP Right Cessation
- 1978-03-28 BE BE186336A patent/BE865391A/fr not_active IP Right Cessation
- 1978-03-28 DE DE19782813384 patent/DE2813384A1/de not_active Withdrawn
- 1978-03-28 ZA ZA00781752A patent/ZA781752B/xx unknown
- 1978-03-28 ES ES468293A patent/ES468293A1/es not_active Expired
- 1978-03-28 CA CA299,789A patent/CA1101409A/fr not_active Expired
- 1978-03-28 LU LU79318A patent/LU79318A1/fr unknown
- 1978-03-28 JP JP3592378A patent/JPS53119862A/ja active Pending
- 1978-03-29 IE IE606/78A patent/IE46592B1/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| FI780938A7 (fi) | 1978-09-29 |
| DK145913B (da) | 1983-04-11 |
| DK135678A (da) | 1978-09-29 |
| FR2385738A1 (fr) | 1978-10-27 |
| FI64378C (fi) | 1983-11-10 |
| AU3451778A (en) | 1979-10-04 |
| IE780606L (en) | 1978-09-28 |
| JPS53119862A (en) | 1978-10-19 |
| CH639109A5 (de) | 1983-10-31 |
| AT361641B (de) | 1981-03-25 |
| NL7803227A (nl) | 1978-10-02 |
| US4130665A (en) | 1978-12-19 |
| ATA207778A (de) | 1980-08-15 |
| AU515232B2 (en) | 1981-03-26 |
| ZA781752B (en) | 1979-03-28 |
| IE46592B1 (en) | 1983-07-27 |
| ES468293A1 (es) | 1978-11-16 |
| HU174575B (hu) | 1980-02-28 |
| FR2385738B1 (fr) | 1980-10-17 |
| CA1101409A (fr) | 1981-05-19 |
| BE865391A (fr) | 1978-09-28 |
| IT7867630A0 (it) | 1978-03-22 |
| DK145913C (da) | 1983-09-19 |
| GB1566905A (en) | 1980-05-08 |
| DE2813384A1 (de) | 1978-10-12 |
| NZ186788A (en) | 1979-10-25 |
| LU79318A1 (fr) | 1978-11-03 |
| FI64378B (fi) | 1983-07-29 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP0160842B1 (fr) | Dérivés d'ergoline substitués sur la position 2, procédés pour leur préparation et leur utilisation comme médicaments | |
| US3966777A (en) | Process for the production of 1α-hydroxy provitamin D3 and 1α-hydroxy vitamin D3 | |
| US4075233A (en) | 16-Dehydro steroids of the androstane series | |
| US3705179A (en) | Antiandrogenic steroids | |
| US2665274A (en) | Steroid pyridinium salts | |
| NO781066L (no) | Fremgangsmaate til fremstilling av nye steroider av androstanserien | |
| EP0217734B1 (fr) | Dérivés d'ergoline bromés dans la position 12 ou 13 | |
| EP0017420B1 (fr) | Dihydroxy-acylanthrones à activité antipsoriatique, procédé pour leur préparation, compositions pharmaceutiques les contenant et leur utilisation comme agent antipsoriatique | |
| NL193317C (nl) | 1,8-Diacyloxy-10-acylantronen en cosmetische en farmaceutische samenstellingen die ze bevatten. | |
| Wolff et al. | The Synthesis of C-18 Functionalized Hormone Analogs. III. Synthesis of Aldosterone1a | |
| US4217279A (en) | Synthesis of steroids | |
| Friedman et al. | Stereospecific rearrangement during the piperidine-catalyzed condensation of benzaldehyde and bis (ethylsulfonyl) methane. Abnormal Knoevenagel condensation | |
| DE3612861A1 (de) | 1-hydroxy-8-acyloxy-10-acylanthrone, verfahren zu deren hersellung und diese verbindungen enthaltende kosmetische und pharmazeutische mittel | |
| Takaya et al. | Oxidation of Dihydrothiophenes with Iodosobenzene | |
| US4464301A (en) | 1,8-Dihydroxy-9-anthrones derivatives substituted in the 10-position by an unsaturated radical and their use in human and veterinary medicine | |
| DE1947221A1 (de) | 3-Aza-19-hydroxy-3,19-cyclo-A-homosteroide und ein Verfahren zu deren Herstellung | |
| US4558069A (en) | 1,8-Dihydroxy-9-anthrones derivatives substituted in the 10-position by an unsaturated radical used in human medicine | |
| DE2256866C3 (de) | Verfahren zur Herstellung von 17 alpha- oder 17beta-Hydroxy-Verbindungen der 20-Ketopregnan- oder -17alpha-pregnanreihe | |
| US2943098A (en) | Pregnadienes and method of preparing the same | |
| DE1111180B (de) | Verfahren zur Herstellung von therapeutisch wirksamen Steroidverbindungen | |
| JPS5842198B2 (ja) | ２−ブロム−６β，９α−ジフルオル−１１β，１７，２１−トリオキシ−１，４−プレグナジエン−３，２０−ジオン−１７，２１−アセトニドの製造方法 | |
| DE1079632B (de) | Verfahren zur Herstellung von 21-Fluorsteroiden | |
| DE2256866B2 (de) | Verfahren zur herstellung von 17 alpha- oder 17beta-hydroxy-verbindungen der 20-ketopregnan- oder -17alpha-pregnanreihe | |
| JPH0362716B2 (fr) | ||
| DE1063164B (de) | Verfahren zur Herstellung einer entzuendungswidrig wirkenden Steroidverbindung |